These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Proatherosclerotic Effect of the α1-Subunit of Soluble Guanylyl Cyclase by Promoting Smooth Muscle Phenotypic Switching. Segura-Puimedon M; Mergia E; Al-Hasani J; Aherrahrou R; Stoelting S; Kremer F; Freyer J; Koesling D; Erdmann J; Schunkert H; de Wit C; Aherrahrou Z Am J Pathol; 2016 Aug; 186(8):2220-2231. PubMed ID: 27315776 [TBL] [Abstract][Full Text] [Related]
16. Role of sulfhydryl-dependent dimerization of soluble guanylyl cyclase in relaxation of porcine coronary artery to nitric oxide. Zheng X; Ying L; Liu J; Dou D; He Q; Leung SW; Man RY; Vanhoutte PM; Gao Y Cardiovasc Res; 2011 Jun; 90(3):565-72. PubMed ID: 21248051 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of ferrochelatase impairs vascular eNOS/NO and sGC/cGMP signaling. Zhang B; Alruwaili N; Kandhi S; Deng W; Huang A; Wolin MS; Sun D PLoS One; 2018; 13(7):e0200307. PubMed ID: 29985945 [TBL] [Abstract][Full Text] [Related]
18. Nitric oxide sensitive guanylyl cyclase activity decreases during cerebral postnatal development because of a reduction in heterodimerization. Haase N; Haase T; Seeanner M; Behrends S J Neurochem; 2010 Jan; 112(2):542-51. PubMed ID: 19895661 [TBL] [Abstract][Full Text] [Related]
19. BAY 60-2770 activates two isoforms of nitric oxide sensitive guanylyl cyclase: Evidence for stable insertion of activator drugs. Sömmer A; Sandner P; Behrends S Biochem Pharmacol; 2018 Jan; 147():10-20. PubMed ID: 29155144 [TBL] [Abstract][Full Text] [Related]